Price $29.05 |
Market Cap
3.17B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
15.7
|
P/B
2.89
|
P/S
0.5
|
Dividend %
3.10%
|
|
P/CF
184.4
|
P/FCF
-
|
Op. Cash Flow
-754.9K
|
FCF
-9.4
|
|
Op. Margin
4.30%
|
Net Margin
3.20%
|
ROE
19.40%
|
ROI
12.90%
|
|
ROA
7.20%
|
EPS Growth
2.40%
|
Current Ratio
1.6
|
Debt/Equity
40.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.82 | - | - | 3.1M | Strong Buy |
| Collegium Pharmaceutical Inc (COLL) | $22.55 | - | - | 743.4M | Strong Buy |
| Precipio Inc (PRPO) | $0.32 | - | - | 10.7M | Strong Buy |
| Aquestive Therapeutics Inc (AQST) | $1.53 | - | - | 92.3M | Strong Buy |
| Item 9 Labs Corp (INLB) | $0.01 | - | - | 5.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
